EXAGEN INC. - COMMON STOCK
3,1656
10-января-25 13:23:56
15 мин. задержка
Акции
-0,1244
-3,78%
Сегодняшний диапазон
3,0500 - 3,3100
ISIN
N/A
Источник
NASDAQ
- Котировки
- Графики
Новости
- Статистика
-
Exagen Inc. Achieves Key Milestone with 1,000,000th Patient Tested by AVISE® CTD
12 дек 2024 09:00:00 Источник Nasdaq GlobeNewswire
-
14 ноя 2024 16:30:00 Источник Nasdaq GlobeNewswire
-
Exagen Inc. to Participate in Fourth Quarter Investor Conferences
13 ноя 2024 16:05:00 Источник Nasdaq GlobeNewswire
-
Exagen Inc. Reports Third Quarter 2024 Results
12 ноя 2024 08:00:01 Источник Nasdaq GlobeNewswire
-
Exagen to Announce Third Quarter 2024 Results on November 12, 2024
29 окт 2024 16:05:00 Источник Nasdaq GlobeNewswire
-
Exagen Announces Acceptance of Five Abstracts at 2024 American College of Rheumatology Convergence
21 окт 2024 16:05:00 Источник Nasdaq GlobeNewswire
-
Exagen Inc. to Participate in the 2024 Cantor Global Healthcare Conference
04 сен 2024 16:05:00 Источник Nasdaq GlobeNewswire
-
Exagen Inc. Reports Strong Second Quarter 2024 Results: Raises Guidance due to Record Performance
05 авг 2024 08:00:00 Источник Nasdaq GlobeNewswire
-
Exagen Inc. to Participate in the Canaccord Genuity 44th Annual Growth Conference
02 авг 2024 09:00:00 Источник Nasdaq GlobeNewswire
-
Exagen Appoints Jeffrey G. Black as New Chief Financial Officer
01 авг 2024 09:00:00 Источник Nasdaq GlobeNewswire
-
Exagen to Announce Second Quarter 2024 Results on August 5, 2024
22 июл 2024 09:00:00 Источник Nasdaq GlobeNewswire
-
Exagen Inc. Reports Strong First Quarter 2024 Results: Raises Guidance for Full Year
13 май 2024 08:00:00 Источник Nasdaq GlobeNewswire
-
Exagen Announces Campaign for Lupus Awareness Month
06 май 2024 16:05:00 Источник Nasdaq GlobeNewswire
-
Exagen to Announce First Quarter 2024 Results on May 13, 2024
30 апр 2024 16:05:00 Источник Nasdaq GlobeNewswire
-
Exagen Inc. Announces Changes to the Board of Directors
26 апр 2024 08:30:00 Источник Nasdaq GlobeNewswire
-
Exagen Inc. Reports Strong Fourth Quarter and Full-Year 2023 Results
18 мар 2024 08:00:00 Источник Nasdaq GlobeNewswire
-
Exagen Inc. to Participate in the KeyBanc Capital Markets Life Sciences & MedTech Investor Forum
08 мар 2024 09:00:00 Источник Nasdaq GlobeNewswire
-
Exagen to Announce Fourth Quarter 2023 and Full-Year Financial Results on March 18, 2024
07 мар 2024 16:05:00 Источник Nasdaq GlobeNewswire
-
30 янв 2024 16:05:00 Источник Nasdaq GlobeNewswire
-
Exagen Inc. Announces Select Preliminary Full-Year 2023 Results and Reaffirms Guidance
07 янв 2024 12:00:00 Источник Nasdaq GlobeNewswire
- <<
- <
- 1
- >